Talus Bio Raises $9.75M Seed Round to Advance MARMOT Platform and Appoints Michelle Briscoe as COO
Talus Bio, a Seattle biotech founded in 2020, raised $9.75 million in seed funding to advance its MARMOT platform for discovering drugs that target hard-to-drug transcription factors and hired Michelle Briscoe as COO.
No comments yet.